Matches in Wikidata for { <http://www.wikidata.org/entity/Q37863795> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- Q37863795 description "article científic" @default.
- Q37863795 description "article scientifique" @default.
- Q37863795 description "articolo scientifico" @default.
- Q37863795 description "artigo científico" @default.
- Q37863795 description "artículu científicu espublizáu n'abril de 2011" @default.
- Q37863795 description "bilimsel makale" @default.
- Q37863795 description "scientific article published on 08 April 2011" @default.
- Q37863795 description "vedecký článok" @default.
- Q37863795 description "vetenskaplig artikel" @default.
- Q37863795 description "videnskabelig artikel" @default.
- Q37863795 description "vědecký článek" @default.
- Q37863795 description "wetenschappelijk artikel" @default.
- Q37863795 description "wissenschaftlicher Artikel" @default.
- Q37863795 description "наукова стаття, опублікована у квітні 2011" @default.
- Q37863795 description "научни чланак" @default.
- Q37863795 description "مقالة علمية نشرت في 08 أبريل 2011" @default.
- Q37863795 name "Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma." @default.
- Q37863795 name "Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma." @default.
- Q37863795 type Item @default.
- Q37863795 label "Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma." @default.
- Q37863795 label "Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma." @default.
- Q37863795 prefLabel "Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma." @default.
- Q37863795 prefLabel "Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma." @default.
- Q37863795 P1433 Q37863795-7624290D-AE67-4530-9E14-F7007218A54C @default.
- Q37863795 P1476 Q37863795-EAFB1E05-7D82-4DFC-8C02-723A9C7C2589 @default.
- Q37863795 P2093 Q37863795-0F671495-372D-4FBC-9C2D-1804E080B78E @default.
- Q37863795 P2093 Q37863795-1C7E1C3F-E724-4861-9005-0E15FEA61EA9 @default.
- Q37863795 P2093 Q37863795-2687661F-4792-4D0C-9425-6671FDFC9295 @default.
- Q37863795 P2093 Q37863795-5B68965C-107B-4106-8398-FD82DFFCDBD4 @default.
- Q37863795 P2093 Q37863795-6709BDA9-C424-4333-AA42-04935D6EE8F2 @default.
- Q37863795 P2093 Q37863795-6ED42F9E-C4D3-4EA5-BA9C-78799D775D52 @default.
- Q37863795 P2093 Q37863795-BCBEE716-72C5-45BF-B590-A20501CFB040 @default.
- Q37863795 P2093 Q37863795-ED344EBB-C85E-4FC3-B453-7AFDC2945D71 @default.
- Q37863795 P304 Q37863795-96ABF9BE-5A3D-4154-BD29-C1A7A1256B09 @default.
- Q37863795 P31 Q37863795-2D532336-3A90-4E5C-B209-EFB243604CAE @default.
- Q37863795 P31 Q37863795-48415dd1-8b96-47bf-a301-4fcc20e1eddd @default.
- Q37863795 P356 Q37863795-A29CA03A-FE75-41F7-9038-0B3876894EC0 @default.
- Q37863795 P433 Q37863795-E0885A30-556C-453A-8FF9-94A5E545779D @default.
- Q37863795 P478 Q37863795-7DE0C525-3032-4AC2-B384-C87DA9EE73F8 @default.
- Q37863795 P50 Q37863795-125F9DA8-8EB3-4200-ABBA-3469B8F4A939 @default.
- Q37863795 P50 Q37863795-B1273770-088C-4D2D-B80F-5C6098F96E26 @default.
- Q37863795 P50 Q37863795-D1CC3EEA-126D-4D32-8AD0-E5E736D31B15 @default.
- Q37863795 P50 Q37863795-DB077EAB-4F3C-4C2B-A383-9B8833AEF696 @default.
- Q37863795 P577 Q37863795-2FD1BFA2-7208-4DEB-8B22-20C4B10E6744 @default.
- Q37863795 P5875 Q37863795-9DC67911-4C7D-4AD1-B802-577EFBA3BDCD @default.
- Q37863795 P698 Q37863795-A21B9ACF-68EB-4315-8A82-51AD4C72F127 @default.
- Q37863795 P8608 Q37863795-35519735-893E-486C-A1B4-E80DF96ECF9D @default.
- Q37863795 P921 Q37863795-5A14385A-A4A4-42CC-969E-2494178FFF2E @default.
- Q37863795 P356 J.EJCA.2011.02.014 @default.
- Q37863795 P698 21481584 @default.
- Q37863795 P1433 Q332260 @default.
- Q37863795 P1476 "Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma" @default.
- Q37863795 P2093 "Brenda Dickow" @default.
- Q37863795 P2093 "Dorothy A White" @default.
- Q37863795 P2093 "Miguel-Angel Climent" @default.
- Q37863795 P2093 "Patricia Creel" @default.
- Q37863795 P2093 "Patricia Fischer" @default.
- Q37863795 P2093 "Susanne Osanto" @default.
- Q37863795 P2093 "Suzanne Sweeney Gornell" @default.
- Q37863795 P2093 "Ulka Vaishampayan" @default.
- Q37863795 P304 "1287-1298" @default.
- Q37863795 P31 Q13442814 @default.
- Q37863795 P31 Q7318358 @default.
- Q37863795 P356 "10.1016/J.EJCA.2011.02.014" @default.
- Q37863795 P433 "9" @default.
- Q37863795 P478 "47" @default.
- Q37863795 P50 Q37393105 @default.
- Q37863795 P50 Q42721742 @default.
- Q37863795 P50 Q56548743 @default.
- Q37863795 P50 Q58414398 @default.
- Q37863795 P577 "2011-04-08T00:00:00Z" @default.
- Q37863795 P5875 "51040418" @default.
- Q37863795 P698 "21481584" @default.
- Q37863795 P8608 "release_xjenrz5vtreirnne2mipwnth7m" @default.
- Q37863795 P921 Q181600 @default.